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It has been suggested that changes in some event-related potential (ERP) parameters
associated with controlled processing of stimuli could be used as biomarkers of
amnestic mild cognitive impairment (aMCI). However, data regarding the suitability of
ERP components associated with automatic and involuntary processing of stimuli for this
purpose are not conclusive. In the present study, we studied the Mismatch Negativity
(MMN) component, a correlate of the automatic detection of changes in the acoustic
environment, in healthy adults and adults with aMCI (age range: 50–87 years). An
auditory-visual attention-distraction task, in two evaluations separated by an interval of
between 18 and 24 months, was used. In both evaluations, the MMN amplitude was
significantly smaller in the aMCI adults than in the control adults. In the first evaluation,
such differences were observed for the subgroup of adults between 50 and 64 years
of age, but not for the subgroup of 65 years and over. In the aMCI adults, the MMN
amplitude was significantly smaller in the second evaluation than in the first evaluation,
but no significant changes were observed in the control adult group. The MMN amplitude
was found to be a sensitive and specific biomarker of aMCI, in both the first and second
evaluation.
Keywords: amnestic mild cognitive impairment, Alzheimer’s disease, event-related potentials, mismatch
negativity, sensory memory, biomarkers
INTRODUCTION
Mild cognitive impairment (MCI) is a heterogeneous clinical
entity characterized by objective evidence of cognitive decline,
without any notable impairment in the performance of daily
activities. It is also considered as an intermediate stage between
the cognitive changes associated with healthy aging and early clin-
ical features of dementia (Petersen, 2004; Winblad et al., 2004).
Among the different subtypes of MCI, amnestic MCI (aMCI) is
the most likely to progress to Alzheimer’s disease (AD) (Petersen
et al., 2001, 2009; Petersen, 2004; Winblad et al., 2004; Albert
et al., 2011), which is the most prevalent form of dementia in the
elderly (Papaliagkas et al., 2009).
The establishment of aMCI biomarkers would be of benefit to
clinicians as the biomarkers could be used as objective diagnos-
tic tools, thus allowing early or pre-symptomatic identification of
AD, aiding treatment decisions, monitoring disease progress, and
providing opportunities for prevention by population screening
(Henry et al., 2012). The methods used to search for biomark-
ers of MCI include neuroimaging techniques (Small et al., 2006;
Hämäläinen et al., 2007), cerebrospinal fluid analysis (Perneczky
et al., 2011), genetic analysis (Zhang et al., 2012) and electroen-
cephalography (EEG), both quantitative EEG (see Jackson and
Snyder, 2008) and event-related potentials (ERPs; see Jackson and
Snyder, 2008 and Vecchio and Määttä, 2011).
The use of ERP technique in the search for aMCI biomarkers
is founded on three essential characteristics designated as ideal
(see Hampel et al., 2010): it is non-invasive, simple to measure
and inexpensive. Moreover, the technique has good temporal res-
olution and allows the study of neurophysiological correlates of
sensory-perceptive and pre-attentive processes, the integrity of
which are essential for the efficient functioning of higher-level
processes and thus the final performance.
Some ERP studies have shown a larger deficit in the controlled
processing of information (such as the evaluation of stimuli in
working memory) in adults with aMCI than in healthy adults
(Golob et al., 2001; Bennys et al., 2007; Missonnier et al., 2007; Lai
et al., 2010; Li et al., 2010; Parra et al., 2012). This deficit appears
to be more evident in aMCI adults that progress to AD than in
those who do not develop AD (Golob et al., 2007; Missonnier
et al., 2007). However, studies concerning ERP correlates of invol-
untary and automatic processing of stimuli in adults withMCI are
scarce and the results are inconclusive.
The mismatch negativity (MMN) component is probably the
most widely studied ERP component in healthy and clinical pop-
ulations, in relation to automatic and pre-attentive processing of
stimuli. Mismatch negativity was first described for the auditory
modality (Näätänen et al., 1978), but has also been reported for
other sensory modalities (for a review see Näätänen et al., 2007).
Auditory MMN is a negative wave commonly derived by
subtracting the ERP waveform evoked by the standard stimu-
lus from that evoked by the deviant stimulus in passive oddball
tasks (which do not require the participant’s attention). In young
adults, the MMN latency is between 100 and 200ms, and the
amplitude is maximal at frontocentral sites (reversing polarity
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at mastoid electrodes). In fact, MMN is considered a correlate
of pre-attentive processes, which are triggered when the sen-
sory input does not match the echoic memory representation of
a prevalent standard stimulus. Therefore, auditory MMN is an
objective index of auditory discrimination (automatic detection
of changes in the acoustic environment) and an indirect measure
of the accuracy of the neural representation of a standard stimulus
(see Näätänen and Alho, 1997).
Among the neural generators of MMN, the bilateral supratem-
poral cortices and predominantly right frontal cortex have been
consistently identified (Näätänen et al., 2007). It has been sug-
gested that the supratemporal component is involved in the
automatic detection of auditory change and that the frontal com-
ponent is related to the involuntary attention switch caused by
auditory change (Giard et al., 1990; Rinne et al., 2000).
Some studies have shown that the MMN amplitude decreases
significantly with age in healthy adults. This has been observed
both when the deviant stimulus differs from the standard in
duration (Pekkonen et al., 1996; Cooper et al., 2006) or tonal
frequency (Czigler et al., 1992; Gaeta et al., 1998; Cooper et al.,
2006) and when novel stimuli are presented (Gaeta et al., 1998).
It has also been observed with long interstimulus intervals (ISIs)
(Czigler et al., 1992; Pekkonen et al., 1996), but not with short ISIs
(2.4 s. or less; Pekkonen et al., 1996; Amenedo and Díaz, 1998;
Raggi et al., 2013; but also see Czigler et al., 1992; Gaeta et al.,
1998; Cooper et al., 2006). In a rather less consistent manner,
the latency of MMN also increases with age (Gaeta et al., 1998;
Cooper et al., 2006).
Two possible explanations for age-related changes in MMN
parameters have been proposed: (i) the sensory memory trace
may be poorer or more degraded in older than in younger sub-
jects, reflecting an inaccurate representation of standard stimuli
by the brain, and/or (ii) a deficient comparator mechanism fails
to detect a mismatch between the representation of the standard
and the deviant stimuli (Gaeta et al., 1998).
In studies with AD patients, changes in MMN have been
observed under some task conditions. For ISIs of 1.3 s or less, no
significant differences between control adults and adults with AD
were observed in theMMN amplitude elicited by changes in tonal
frequency (Pekkonen et al., 1994; Kazmerski et al., 1997; Gaeta
et al., 1999; Brønnick et al., 2010) or by presentation of novel
stimuli (Kazmerski et al., 1997; Gaeta et al., 1999). However, in
AD patients the MMN amplitude was significantly smaller for an
ISI of 3 s than for the shorter ISI condition (1 s), while in control
adults the MMN amplitude was stable across both ISIs (Pekkonen
et al., 1994). These results suggest that sensory memory trace
decays faster in AD patients than in healthy controls, although
auditory discrimination was not affected (Pekkonen et al., 1994).
In the only published study to date evaluating the effect ofMCI
onMMN parameters, Mowszowski et al. (2012) recorded ERPs in
a sample of 14 healthy adults and 28 adults with MCI, in a passive
oddball task in which the standard and deviant stimuli differed in
duration (standard: 50ms, deviant: 100ms). In the MCI group,
all participants showed impairment in several cognitive domains.
Of these, half were amnestic subtype (aMCI) Multiple Domain
and half non-amnestic subtype (naMCI) Multiple Domain. The
authors found no differences between the MCI and control
groups in MMN amplitude or latency, or between the aMCI
and naMCI subtypes at frontocentral locations. However, they
did observe that at mastoid locations, the MMN amplitude was
smaller in the MCI group than in the control group, which
the authors considered reflect of the inefficiency of processing
information in an early pre-attentional stage in the MCI group.
The recent study by Mowszowski et al. (2012) provided some
interesting results, but also presented some limitations. Thus, the
differences in MMN amplitude between MCI and control adults
were obtained at mastoid electrodes, but not at the frontocen-
tral locations, where MMN is typically identified and analyzed.
Moreover, the analysis did not take into account the possi-
ble effects of interactions between the Age and Group factors,
although previous studies have reported age effects on MMN
amplitude to changes of stimuli duration (Pekkonen et al., 1996;
Gaeta et al., 1998; Cooper et al., 2006). Moreover, the MCI
group was heterogeneous, as it included both amnestic and non-
amnestic multidomain MCI patients.
The aims of the present study were as follows: (1) to deter-
mine any differences in MMN parameters between healthy adults
and adults with aMCI; (2) to evaluate whether such differences
between healthy adults and adults with aMCI are affected by age,
by considering two age subgroups (50–64 years and 65 years and
over); (3) to determine whether the differences in MMN parame-
ters between healthy and aMCI adults are maintained in a second
evaluation, conducted 18–24 months after the first evaluation,
and (4) to evaluate whether MMN changes associated with aMCI
are sensitive and specific biomarkers of this syndrome.
We used an auditory-visual attention-distraction task [based
on the task designed by Escera et al. (1998), see Methods section].
This task was presented to a sample of healthy control adults and
adults with aMCI during two evaluations separated by an interval
of between 18 and 24 months. Auditory MMN was obtained by
subtracting the ERP waveform evoked by standard stimuli from
the waveform evoked by the deviant or novel stimuli (deviant
minus standard, and novelminus standard).
To our knowledge, this is the first study designed to determine
whether MMN parameters (amplitude and/or latency) are sensi-
tive and specific biomarkers of aMCI, whether their effectiveness
in identifying adults with this syndrome interacts with age, and
also whether the MMN parameters change over time in healthy
control and aMCI adults.
MATERIALS AND METHODS
PARTICIPANTS
Participants were 56 healthy adult volunteers (35 women, 21
men; age range: 50–87 years old; mean = 65.7 years, SD =
9.1), recruited from Primary Care Health Centres in Santiago
de Compostela and Vigo (Galicia, Spain) and referred to our
research group by their general practitioners (GPs). The partic-
ipants had no history of clinical stroke, traumatic brain injury,
motor-sensory defects, or alcohol or drug abuse/dependence, and
they were not diagnosed with any significant medical or psy-
chiatric illnesses. To control for the effects of depression, adults
with a score of more than 10 in depression screening (Geriatric
Depression Scale, GDS; Yesavage et al., 1983) were excluded from
the study. All participants had normal audition and normal or
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corrected-to-normal vision. Most of them were right-handed, as
assessed by the Edinburgh inventory (Oldfield, 1971), except for
one left-handed and one ambidextrous participant.
After giving their written informed consent, participants were
referred by their GPs to the Psychogerontology Group (see
Juncos-Rabadán et al., 2013) with whom we participate in a col-
laborative research project. They conducted the neuropsycholog-
ical evaluation and the clinical diagnosis of MCI. The participants
were then referred to our laboratory for psychophysiological
(ERP) evaluation.
The participants provided us with information about years of
education, as well as socioeconomic, medical and personal data,
received extensive psychological and neuropsychological evalu-
ations, and were diagnosed and classified as control or aMCI.
They underwent the following tests: (1) The Mini-Mental State
Examination (MMSE, Folstein et al., 1975; Spanish version, MEC
by Lobo et al., 1999), which assesses general cognitive func-
tioning; (2) The Californian Verbal Learning Test [CVLT, Delis
et al., 1987; Spanish version, TAVEC by Benedet and Alejandre
(1998)], which assesses short-delay free recall, short-delay recall
with semantic cues, and long-delay free recall; (3) The Spanish
version of the Cambridge Cognitive Examination (CAMCOG-R),
which assesses deterioration in specific domains such as lan-
guage, attention-calculation, praxis, perception, and executive
functioning (Huppert et al., 1996) and is sensitive to MCI detec-
tion (Gallagher et al., 2010); and (4) The Spanish version of the
vocabulary test of the Wechsler Adult Intelligence Scale (WAIS,
Wechsler, 1988).
Two evaluations, separated by an interval of between 18 and
24 months, were carried out. In the first evaluation, the Control
group (CG) comprised 30 adults aged between 50 and 84 years
(mean: 63.9 years, SD: 8.4) with normal cognitive and mem-
ory functioning, and the aMCI group comprised 26 adults aged
between 51 and 87 years (mean: 67.8 years, SD: 9.3). In the sec-
ond evaluation, only 27 (18 control and 9 aMCI) of the initial
sample of 56 participants agreed to participate in the ERP record-
ings. Two of the 18 control adults and 1 of the 9 aMCI adults
were excluded because of excessive artifacts in their recording,
and 1 aMCI adult died. Nine of the 16 control adults with valid
recordings were selected with the aim of matching their ages with
the aMCI group. Consequently, the final sample in the second
evaluation consisted of 16 adults: 9 control adults (range age:
59–73 years) and 7 aMCI adults (range age: 62–89 years), whose
diagnosis was maintained between evaluations.
In both evaluations, control adults scored higher than the
cut-off on memory, general cognitive functioning, and specific
cognitive domain tests. The aMCI subjects met the general cri-
teria for MCI outlined by Albert et al. (2011) and the criteria
for aMCI proposed by Petersen and colleagues (Petersen, 2004;
Dubois et al., 2007).
The aMCI adults fulfilled the following criteria: (1) mem-
ory complaints corroborated by an informant; (2) performance
of less than 1.5 SDs below age norms for the CVLT; (3) no
significant impact on daily living activities; and (4) without
dementia, according to the National Institute of Neurological
and Communicative Diseases and Stroke/Alzheimer’s Disease
and Related Disorders Association (NINCDS-ADRDA) and the
Diagnostic and Statistical Manual of Mental Disorders (DMS-
IV) criteria. The Lawton and Brody Index (Lawton and Brody,
1969) was used to evaluate instrumental activities of daily liv-
ing (IADL). Nine of the aMCI adults fulfilled criteria for multiple
domain amnestic MCI (mda-MCI), and 17 subjects fulfilled cri-
teria for single domain amnestic MCI (sda-MCI). With respect
to general cognitive functioning, the mda-MCI subjects scored
less than 1.5 SDs below age- and education-related norms in the
MEC and in at least two cognitive subscales of the CAMCOG-
R. For the analysis of the present study, the two subgroups of
aMCI were not differentiated, because they did not show any dif-
ferences in MMN parameters (see Results section), and they were
consequently regrouped into a single group of adults with aMCI.
The research project was approved by the Galician Clinical
Research Ethics Committee (CEIC) and performed in accordance
with the ethical standards established in the 1964 Declaration of
Helsinki (Lynöe et al., 1991).
STIMULI AND TASK
An auditory-visual attention-distraction task adapted from
Escera et al. (1998, 2001) was used. This included a passive audi-
tory oddball task and an active Go/NoGo three-stimuli visual
oddball task. Participants were presented with 500 auditory-visual
(A-V) stimuli pairs (divided in two blocks separated by a 2-min
rest interval). Each pair included an auditory stimulus (150ms
duration) followed by a visual stimulus (200ms duration), with
an interval of 300ms (onset-to-onset) between them, and a 2-s
interval between each pair. Participants were asked to attend to
the visual stimuli and ignore the auditory stimuli.
Auditory stimuli were sounds, presented binaurally via head-
phones, with 75 dB SPL intensity. Three kinds of sounds were
presented: 70% were standard stimuli (tone bursts, 1000Hz),
15% were deviant stimuli (tone bursts, 2000Hz), and 15% were
novel stimuli (different each time: glass crashing, ringing, etc . . .).
Visual stimuli were numbers (2, 4, 6, or 8), letters (a, e, c, or u)
or triangles (pointing up, down, right, or left). Participants were
asked to respond to the numbers (33%) with one hand and to the
letters (33%) with the other hand, by pressing a different button
in each case (Go condition), and they were asked to inhibit their
responses to triangles (34%, NoGo condition). Response buttons
were counterbalanced among participants. For this task, each par-
ticipant underwent two evaluations separated by an interval of
between 18 and 24 months.
ELECTROENCEPHALOGRAPHIC (EEG) RECORDING
The participants were seated on a comfortable chair in a Faraday
chamber, with attenuated levels of light and noise, and were
instructed to move as little as possible during the recording.
Visual stimuli were presented with a subtended visual angle of
1.7◦ × 3.3◦ of arc, on a 19′′ flat screen monitor with a vertical
refresh rate of 120Hz. The monitor was located one meter away
from the participant. The electroencephalogram was recorded
from 49 ring electrodes placed in an elastic cap (Easycap, GmbH),
according to the International 10-10 system. All electrodes were
referenced to an electrode attached to the tip of the nose, and
an electrode positioned at Fpz served as ground. The horizon-
tal electro-oculogram (EOG) was recorded from two electrodes
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placed at the outer canthi of both eyes, and the vertical EOG was
recorded from two electrodes placed supra and infra-orbitally on
the right eye. The EEG was continuously digitized at a rate of
500Hz (bandpass 0.01–100Hz), and electrode impedances were
kept below 10 k.
Once the signal was stored, ocular artifacts were corrected and
the EEG was then segmented by extraction of -100 to 650ms
epochs, synchronized with each auditory stimuli. These were then
classified a posteriori as Standard, Deviant and Novel, depending
on the type of auditory stimulus. The signal was passed through a
digital 0.1–30Hz (24 dB/octave slope) bandpass filter and epochs
were corrected to the mean voltage of the 100-ms pre-stimulus
recoding period. EEG segments exceeding ±100µV and the first
five epochs of each block were automatically excluded from the
averages. Finally, to identify and measure MMN, we obtained the
deviant minus standard (D-S) and novel minus standard (N-S)
difference waveforms.
DATA ANALYSES
The MMN component was identified as a negative wave in the
125–260ms interval, and it was evaluated at the Cz electrode site
(where the amplitude was maximal). The polarity of the com-
ponent was reversed at temporal (TP9 and TP10) electrode sites
(see Figure 1).
In the first evaluation, the MMN component was identified
in the N-S and D-S difference waveforms, for the two groups
of participants (CG and aMCI group). In the second evaluation,
MMN was also identified in the N-S and D-S difference traces for
FIGURE 1 | Grand-average event-related potentials waveforms,
measured at Cz (top), during the 350ms after the stimulus, and voltage
and current source density (CSD) maps for MMN maximum peak
(bottom), in the novel minus standard difference waveforms, for control
and aMCI adults, in the first (for the two age subgroups) and second
evaluations.
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the control adults; however, for the aMCI adults, MMN was only
identified in the N-S difference trace and it was absent in the D-S
difference trace.
TheMMN amplitude (in microvolts, from the maximum peak
to the baseline) and latency (in milliseconds, from the auditory
stimulus onset to the maximum peak) were measured. Current
source density (CSD) and voltage maps were also obtained for
topographic analysis.
STATISTICAL ANALYSES
In the first evaluation, one-factor analysis of variance (ANOVA)
was used to investigate the effect of the Group factor on the
MMN amplitude and latency (measured at Cz) in the N-S and
D-S difference waveforms. The analysis considered a dependent
variable (MMN amplitude or latency) and an independent fac-
tor (Group, three levels: CG, sda-MCI, and mda-MCI groups).
As there were no significant differences between aMCI subgroups
for MMN parameters, both subgroups were regrouped as a single
aMCI group for the following analysis.
Two-factor ANOVAs was used to investigate the effect of
Group and Age factors on theMMN amplitude and latency (mea-
sured at Cz) in the N-S and D-S waveforms. The analysis included
a dependent variable (MMN amplitude or latency) and two inde-
pendent factors, Group (two levels: CG, and aMCI) and Age (two
levels: middle-aged adults: 50–64 years, and older adults: 65 years
and over).
In the second evaluation, a one-factor ANOVAs (Group) was
used to investigate the Group factor effect on theMMNamplitude
and latency (measured at Cz) in the N-S difference waveforms.
The Age factor was not evaluated because of the small number
of participants (9 in the CG and 7 in the aMCI group). In this
evaluation, the effect of the Group factor on MMN in the D-S
difference was not evaluated because no MMN component was
observed in this difference waveform in aMCI adults.
Finally, t-tests for related samples were used to evaluate the
changes in the MMN parameters (in the N-S difference wave-
form) between the first and the second evaluation, in each group
of participants (9 control adults and 7 aMCI adults).
When the ANOVAs revealed significant factor and interactions
effects, further comparisons of the mean values were carried out
by paired multiple comparisons (adjusted to Bonferroni correc-
tion). Differences were considered significant at p < 0.05.
The receiver-operating characteristics (ROC) method was
used to assess the capacity of MMN parameters to discriminate
aMCI adults from control adults. A line diagram was constructed
with the sensitivity (true positive rate) plotted on the vertical axis
and the false positive rate (1minus specificity) on the horizontal
axis. The ROC curve was constructed by finding the sensitivity
and specificity for a range of values of the continuous variable
(MMN parameters). The tests were considered to be ideal when
the area under the curve (AUC) was higher than 0.7.
All statistical analyses were performed with IBM SPSS
Statistics package v.19 for Windows.
RESULTS
DEMOGRAPHIC AND NEUROPSYCHOLOGICAL DATA
In both evaluations, the groups were matched according to age
and level of education. The demographic and neuropsychological
Table 1 | Mean values and standard deviations (in parentheses) of the
demographic and neuropsychological measures, for control and
amnestic MCI (aMCI) adults.
Control aMCI p<
FIRST EVALUATION N = 30 N = 26
Age 63.9 (8.4) 67.8 (9.3) NS
Years of education 9.4 (4.4) 10.15 (4.7) NS
Gender (F/M) 21/9 14/12
WAIS, vocabulary 49.9 (11.7) 46.7 (13.4) NS
MMSE 28.5 (0.9) 25.8 (2.1) 0.001 Control > aMCI
CVLT (short-delay free
recall)
10.2 (2.3) 3.9 (1.8) 0.001 Control > aMCI
CVLT (short-delay cued
recall)
12 (2.3) 5.8 (2.2) 0.001 Control > aMCI
CVLT (long-delay free
recall)
11.4 (2.2) 4.5 (3) 0.001 Control > aMCI
Depression (GDS) 2.9 (2.1) 3.8 (3.1) NS
SECOND EVALUATION N = 9 N = 7
Age 66.6 (5.5) 74.4 (10.1) NS
Years of education 8.2 (4.3) 11.1 (4.5) NS
Gender (F/M) (7/2) (3/4)
WAIS, vocabulary 46.4 (9) 49 (16.7) NS
MMSE 28.1 (1.2) 23.3 (5.1) 0.01 Control > aMCI
CVLT (short-delay free
recall)
11.6 (2.9) 2.7 (2.6) 0.001 Control > aMCI
CVLT (short-delay cued
recall)
13 (1.9) 5 (2.5) 0.001 Control > aMCI
CVLT (long-delay free
recall)
12.3 (3.3) 4.7 (3.6) 0.001 Control > aMCI
Depression (GDS) 2.2 (0.9) 2.7 (1.1) NS
The ANOVA results for the Group factor are also shown.
measurements are summarized in Table 1, together with the
between-group differences calculated by the corresponding anal-
ysis. For an extensive description of the global samples, the
inclusion/exclusion criteria, the tests used, and the diagnosis and
classification criteria, see Juncos-Rabadán et al. (2013).
ERPs
The factors under consideration did not have any significant
effects on the MMN latency or amplitude in the D-S difference
waveforms. Therefore, we will report only the results obtained for
MMN in the N-S difference waveforms, for both the first and the
second evaluation.
ThemeanMMN amplitudes (µV) and latencies (ms) obtained
in both evaluations are shown in Table 2. The grand average ERP
waveforms of the N-S difference traces and the voltage and CSD
maps for MMN maximum amplitude peaks in the first and the
second evaluations are shown in Figure 1. Voltagemaps forMMN
revealed larger amplitudes for the CG than for the aMCI group.
In both groups, the CSD maps showed bilateral sinks at tem-
poroparietal scalp regions and a right frontal source. However,
between-group topographical differences in CSD maps were also
observed. During the first evaluation, a widespread centroparietal
source was observed in control adults in the older age subgroup
(65 years and over) and in aMCI adults in the middle-aged
Frontiers in Aging Neuroscience www.frontiersin.org November 2013 | Volume 5 | Article 79 | 5
Lindín et al. MMN amplitude as aMCI biomarker
Table 2 | Mean values and standard deviations (in parentheses) of the auditory MMN amplitudes (in µV) and latencies (in ms), measured at the
Cz electrode, in the novel minus standard (N-S) and deviant minus standard (D-S) difference waveforms, for the two diagnostic groups
(control and amnestic MCI adults).
Group Age N-S MMN D-S MMN
Amplitude Latency Amplitude Latency
FIRST EVALUATION
Control adults (N = 30) 50–64 (N = 15)
(M: 56.8 years, SD: 3.9)
−5.3 (3.3) 207 (27) −1.9 (2.0) 228 (25)
≥65 (N = 15)
(M: 71.1 years, SD: 4.9)
−2.6 (2.2) 202 (33) −1.1 (1.5) 207 (32)
aMCI adults (N = 26) 50–64 (N = 10)
(M: 58.8 years, SD: 4.3)
−2.1 (2.8) 187 (35) −1.2 (1.2) 208 (27)
≥65 (N = 16)
(M: 73.5 years, SD: 6.7)
−2.5 (2.2) 186 (34) −2.2 (2.1) 201 (33)
SECOND EVALUATION
Control adults (N = 9) 59–73
(M: 66.6 years, SD: 5.5)
−4.7 (3.5) 205 (56) −1.9 (1.2) 210 (35)
aMCI adults (N = 7) 62–89
(M: 74.4 years, SD: 10.1)
−1.1 (2.0) 192 (34) – –
In the first evaluation, the data for the two age subgroups (50–64 years and 65 years and over) in each group (control and aMCI) are shown.
M: mean, SD: standard deviations.
subgroup (50–64 years); however, this source was not observed in
the middle-aged control adults or in the older adults with aMCI.
First evaluation
ForMMN latency, the two-factor ANOVA (Group×Age) showed
significant effects of the Group factor [F(1, 52) = 4.1, p < 0.048],
as latency was significantly shorter in the aMCI group than in
the CG. For MMN amplitude, the two-factor ANOVA revealed
significant effects of the Group factor [F(1, 52) = 5.4, p < 0.023]
and the Group × Age interaction [F(1, 52) = 4.9, p < 0.031],
because the amplitude was significantly larger (p < 0.004) in the
CG than in the aMCI group, only for the middle-aged subgroup
(50–64 years). Furthermore, for the CG, the amplitude was sig-
nificantly larger (p < 0.008) in the middle-aged than in the older
adults.
Second evaluation
For MMN latency, the one-factor ANOVA revealed no significant
factor (Group) effect. For MMN amplitude, the ANOVA showed
significant effect of the Group factor [F(1, 14) = 5.66, p < 0.032],
as the amplitude was significantly larger for the CG than for the
aMCI group.
First vs. Second evaluation
The t-test for related samples did not show any significant differ-
ences for the MMN latency between the first and second evalu-
ations. However, for the MMN amplitude, the analysis revealed
significant differences within the aMCI group, as the MMN
amplitude was significantly smaller in the second evaluation
(−1.1µV) than in the first evaluation (−2.8µV) [t(6) = −2.9,
p < 0.027]. The MMN amplitude and latency in the control
FIGURE 2 | Means and standard deviations for MMN amplitudes (in
µV) in the novel minus standard difference, in the first and the second
evaluations, for control (N = 9) and aMCI (N = 7) adults.
group did not differ significantly between the first and second
evaluations (see Figure 2).
SENSITIVITY AND SPECIFICITY
The ROC curves for MMN amplitudes (N-S difference wave-
forms), in the first and second evaluations, for the aMCI group
and CG comparisons are shown in Figure 3.
In the first evaluation, MMN amplitude showed 0.7 sensitivity
and 0.66 specificity (AUC = 0.76) for the discrimination between
aMCI and control middle-aged adults. However, the MMN
latency showed very low sensitivity and specificity (AUC = 0.34).
In the second evaluation, the MMN amplitude was also sensitive
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FIGURE 3 | Receiver-operating characteristics (ROC) curves are
represented for MMN amplitudes in novel minus standard difference,
in the first and the second evaluations, for the aMCI and control adults
comparison. Left: MMN amplitude for the middle-aged subgroup in the
first evaluation. Right: MMN amplitude in the second evaluation.
and specific in discrimination between aMCI and control groups,
with 0.71 sensitivity and 0.78 specificity (AUC = 0.82).
DISCUSSION
Mismatch negativity (MMN) component was identified in both
groups of participants (control and aMCI). As expected, CSD
maps showed bilateral sinks at temporal scalp regions and a
right frontal source for this component, presumably reflecting the
MMN generator activity, located in the auditory supratemporal
cortices and the frontal cortex, respectively (see Näätänen et al.,
2007).
Control and aMCI adults showed differences for MMN com-
ponent of the N-S difference waveforms in two evaluations sep-
arated by an interval of between 18 and 24 months. In the first
evaluation, the MMN amplitude was significantly smaller in the
aMCI adults than in the control adults, though only for the
middle-aged subgroup (between 50 and 64 years of age). The
MMN latency was significantly shorter in the aMCI group than in
the CG. In the second evaluation, the MMN amplitude was also
significantly smaller in the aMCI group than in the CG, and the
aMCI group showed a decrease in MMN amplitude from the first
to the second evaluation, whereas the CG did not show significant
changes between evaluations.
MMN LATENCY
In the first evaluation, the MMN latency was significantly shorter
in the aMCI group than in the CG. In the second evaluation,
although the mean values and SD for both groups were similar
to those of the first evaluation, the Group factor was not statis-
tically significant, probably because the sample size was smaller
in the second evaluation. This result is intriguing because no
significant differences in MMN latencies were observed in other
MMN studies comparing AD patients and healthy control sub-
jects (Kazmerski et al., 1997; Gaeta et al., 1999; Brønnick et al.,
2010) or in the only previous study comparing a MCI group with
a control group (Mowszowski et al., 2012).
Although the shorter MMN latency in the aMCI group than
in the CG in the first evaluation of this study must be consid-
ered with caution. Interestingly, Mowszowski et al. (2012) also
observed slightly shorter (but non-significant) MMN latencies
(measured at Fz and Cz electrodes) in the MCI than in the
control group (see Table 2, page 214, of the cited study). We ten-
tatively speculate that in participants with aMCI, earlier closure
of the comparison (in echoic memory) of each novel stimu-
lus with the stored model of a standard stimulus may occur,
resulting in a mismatch. This early closure may be premature
and related to the deterioration of echoic memory. However,
this hypothesis must be addressed in greater detail in future
studies.
MMN AMPLITUDE
In the first evaluation, the MMN amplitude was significantly
larger in the CG than the aMCI group, only for the middle-
aged subgroup (50–64 years). This may indicate some impair-
ment, in the middle-age aMCI adults, of the automatic detection
mechanism of disparities when the novel stimuli are presented.
This mechanism depends on maintaining an echoic memory
trace of the standard stimulus, with which it automatically
compares each novel (or deviant) stimuli presented. Näätänen
et al. (2011, 2012) suggested that MMN deficits may be at least
partly explained by dysfunction of the N-methyl-D-aspartate
(NMDA) receptor system, which usually binds to the neuro-
transmitter glutamate. Consequently, reduced MMN in aMCI
adults may signify a more general functional deficiency involv-
ing glutamatergic dysfunction, as suggested by Mowszowski et al.
(2012).
The ROC analysis for the first evaluation showed that MMN
amplitude could be considered a biomarker of aMCI in middle-
aged adults, discriminating between the two groups with a sen-
sitivity of 0.70 and specificity of 0.66 (AUC = 0.76, in ROC
curves).
For adults 65 years old or more, there were no differences in
MMN amplitude between the control and aMCI groups. This is
probably due to a significant age-related decrease inMMN ampli-
tude in the CG, as also found by Gaeta et al. (1998). For the
aMCI group, the MMN amplitude did not differ between the two
age subgroups. Thus, in the older adults (65 years and over), the
lack of differences between the CG and the aMCI group may be
due to an age-related decline in the mechanism for echoic mem-
ory trace maintenance and/or the pre-attentional mechanisms
involved in the automatic detection of differences in the acous-
tic environment, which may mask the effects of aMCI on that
parameter.
The CSD maps for MMN showed similar sources and sinks
in control and aMCI adults. These maps also revealed differ-
ences in the first evaluation, which are consistent with the results
obtained for the MMN parameters in the present work. Thus,
they revealed a centroparietal source in middle-aged adults (50–
64 years) with aMCI, but not in the middle-aged control adults,
which is consistent with the significant between-group differences
(control and aMCI adults) for MMN amplitude. Moreover, in
accordance with the observed effects of aging on theMMN ampli-
tude in the control group, this source was also observed in the
older control adults (65 years and over). Within the framework of
the Scaffolding Theory of Aging and Cognition (STAC) proposed
by Park and Reuter-Lorenz (2009), we believe that the said source
may reflect a brain that is adapting, through neural scaffolding,
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to the functional and structural changes that appear, either due to
aMCI in middle–aged adults or to healthy aging.
The present ERP results are partly consistent with those
obtained by Mowszowski et al. (2012) for the MMN amplitude
evoked by deviant stimuli, which differed from the standard
stimuli in duration (100 and 50ms, respectively). These authors
observed a larger MMN amplitude in healthy adults than in a
multi-domainMCI group (for an age range of 50–90 years in both
groups), although only at mastoid locations, where MMN shows
polarity reversal, but not at the frontocentral locations, where the
amplitude of this negative component is maximal.
Our results are also consistent with those reported by
Pekkonen et al. (1994) for AD patients and healthy controls. These
authors observed a significant decrease inMMN amplitude, in the
AD group, from an ISI of 1 s to an ISI of 3 s, which they inter-
preted as a weakening of echoic memory trace with increasing ISI
in people with AD. In the present study, the interval between audi-
tory stimuli was 2.35 s. We also presented visual stimuli between
the auditory stimuli, which required attention and often response.
The combination of both factors may have affected the main-
tenance of echoic memory trace of standard auditory stimuli in
aMCI participants, but not in CG participants.
In the second evaluation (conducted between 18 and 24
months after the first), comparison of the MMN parameters in
a subsample of participants again showed a significantly larger
MMN amplitude in control adults than in adults with aMCI.
As found in the first evaluation, the MMN amplitude may be
considered a biomarker of aMCI, discriminating between the
two groups with 0.71 sensitivity and 0.78 specificity (AUC =
0.82, in ROC curves). Moreover, the characteristics of the MMN
component make it an ideal biomarker: it is an automatic ERP
component, which is not dependent on the attention given by the
subject to the task and, moreover, it is obtained in a non-invasive
manner and is simple and inexpensive to measure.
The MMN amplitude was also significantly smaller in the sec-
ond evaluation than in the first in the group with aMCI, while it
did not differ between evaluations in the CG. This may indicate
a progressive deterioration, in aMCI adults, of the neural mech-
anisms involved in the maintenance of sensory trace and/or the
pre-attentive mechanisms for automatic detection of changes in
the acoustic environmental. The findings highlight the impor-
tance of longitudinal studies in determining the evolution of
deficits detected in a first assessment in participants with aMCI, as
well as the diagnostic and prognostic value of psychophysiological
markers.
This study is not without limitations, mainly due to the small
sample size in the second evaluation. Future studies, with a large
sample of participants in all follow-up evaluations, should (1)
confirm the effect of the interaction between age and diagnos-
tic group on MMN amplitude, and (2) determine any differences
in how the MMN amplitude decreases over time in adults with
MCI who progress to AD and in adults with MCI who do not
develop AD.
Despite these limitations, the present study showed that the
MMN amplitude was smaller in adults with aMCI than in control
adults (in the middle-aged subgroup in the first evaluation and
in the whole sample in the second evaluation, conducted between
18 and 24 months after the first). In addition, in participants with
aMCI, the MMN amplitude was smaller in the second evaluation
than in the first, whereas no difference was observed in the control
group. The results of this study suggest that MMN amplitude can
be a fairly sensitive and specific psychophysiological biomarker
for the identification of adults with aMCI.
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